Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib
Crossref DOI link: https://doi.org/10.1007/s12094-014-1189-3
Published Online: 2014-06-04
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zheng, J.
Shao, G.
Luo, J.
Text and Data Mining valid from 2014-06-04